TUSTIN, Calif., Sept. 13 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL - News), developer and marketer of tests for the early detection of cancer and other serious diseases, announced today that it has retained the statistical and regulatory consulting firm R. P. Chiacchierini & Associates, LLC, Rockville, Maryland, (http://www.rpcaconsulting.com) to provide additional statistical analysis for the U.S. Food and Drug Administration (FDA) to support the Company’s request for clearance to market its DR-70® cancer test kit in the U.S.
